Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 378 entries
Sorted by: Best Match Show Resources per page
The Evolution of Radiation Therapy for Retinoblastoma: The MD Anderson Cancer Center Experience.

International journal of particle therapy

Agarwal A, Thaker NG, Tawk B, Allen PK, Grosshans DR, Herzog CE, Gombos DS, Mahajan A.
PMID: 31772961
Int J Part Ther. 2016 Mar;2(4):490-498. doi: 10.14338/IJPT-15-00016.1. Epub 2016 Mar 24.

PURPOSE: The role of radiation therapy (RT) for retinoblastoma (Rb) has significantly evolved from first-line to salvage therapy. The objectives of our study were to evaluate efficacy of proton RT (PRT) and other advanced RT techniques for Rb and...

Cite
Agarwal A, Thaker NG, Tawk B, et al. The Evolution of Radiation Therapy for Retinoblastoma: The MD Anderson Cancer Center Experience. Int J Part Ther. 2016;2(4):490-498doi: 10.14338/IJPT-15-00016.1.
Agarwal, A., Thaker, N. G., Tawk, B., Allen, P. K., Grosshans, D. R., Herzog, C. E., Gombos, D. S., & Mahajan, A. (2016). The Evolution of Radiation Therapy for Retinoblastoma: The MD Anderson Cancer Center Experience. International journal of particle therapy, 2(4), 490-498. https://doi.org/10.14338/IJPT-15-00016.1
Agarwal, Ankit, et al. "The Evolution of Radiation Therapy for Retinoblastoma: The MD Anderson Cancer Center Experience." International journal of particle therapy vol. 2,4 (2016): 490-498. doi: https://doi.org/10.14338/IJPT-15-00016.1
Agarwal A, Thaker NG, Tawk B, Allen PK, Grosshans DR, Herzog CE, Gombos DS, Mahajan A. The Evolution of Radiation Therapy for Retinoblastoma: The MD Anderson Cancer Center Experience. Int J Part Ther. 2016 Mar;2(4):490-498. doi: 10.14338/IJPT-15-00016.1. Epub 2016 Mar 24. PMID: 31772961; PMCID: PMC6871642.
Copy Download .nbib Format: NLM
Unveiling the Patterns of Reticulated Evolutionary Processes with Phylogenomics: Hybridization and Polyploidy in the genus Rosa.

Systematic biology

Debray K, Le Paslier MC, Bérard A, Thouroude T, Michel G, Marie-Magdelaine J, Bruneau A, Foucher F, Malécot V.
PMID: 34329460
Syst Biol. 2021 Jul 30; doi: 10.1093/sysbio/syab064. Epub 2021 Jul 30.

Reticulation, caused by hybridization and allopolyploidization, is considered an important and frequent phenomenon in the evolution of numerous plant lineages. Although both processes represent important driving forces of evolution, they are mostly ignored in phylogenetic studies involving a large...

Cite
Debray K, Le Paslier MC, Bérard A, et al. Unveiling the Patterns of Reticulated Evolutionary Processes with Phylogenomics: Hybridization and Polyploidy in the genus Rosa. Syst Biol. 2021;doi: 10.1093/sysbio/syab064.
Debray, K., Le Paslier, M. C., Bérard, A., Thouroude, T., Michel, G., Marie-Magdelaine, J., Bruneau, A., Foucher, F., & Malécot, V. (2021). Unveiling the Patterns of Reticulated Evolutionary Processes with Phylogenomics: Hybridization and Polyploidy in the genus Rosa. Systematic biology, . https://doi.org/10.1093/sysbio/syab064
Debray, Kevin, et al. "Unveiling the Patterns of Reticulated Evolutionary Processes with Phylogenomics: Hybridization and Polyploidy in the genus Rosa." Systematic biology vol. (2021). doi: https://doi.org/10.1093/sysbio/syab064
Debray K, Le Paslier MC, Bérard A, Thouroude T, Michel G, Marie-Magdelaine J, Bruneau A, Foucher F, Malécot V. Unveiling the Patterns of Reticulated Evolutionary Processes with Phylogenomics: Hybridization and Polyploidy in the genus Rosa. Syst Biol. 2021 Jul 30; doi: 10.1093/sysbio/syab064. Epub 2021 Jul 30. PMID: 34329460.
Copy Download .nbib Format: NLM
New method for screening anti-Leishmania compounds in plants extracts by HPTLC-bioautography.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Hilaire V, Michel G, Majoor A, Hadji-Minaglou F, Landreau A, Fernandez X.
PMID: 34894478
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Dec 04;1188:123061. doi: 10.1016/j.jchromb.2021.123061. Epub 2021 Dec 04.

Leishmania genus is responsible for leishmaniasis, a group of diseases affecting 12 million people in the tropical and subtropical zone. Currently, the few drugs that are available to treat this disease are expensive and cause many side effects. Searching...

Cite
Hilaire V, Michel G, Majoor A, et al. New method for screening anti-Leishmania compounds in plants extracts by HPTLC-bioautography. J Chromatogr B Analyt Technol Biomed Life Sci. 2021;1188:123061doi: 10.1016/j.jchromb.2021.123061.
Hilaire, V., Michel, G., Majoor, A., Hadji-Minaglou, F., Landreau, A., & Fernandez, X. (2021). New method for screening anti-Leishmania compounds in plants extracts by HPTLC-bioautography. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1188123061. https://doi.org/10.1016/j.jchromb.2021.123061
Hilaire, Valentin, et al. "New method for screening anti-Leishmania compounds in plants extracts by HPTLC-bioautography." Journal of chromatography. B, Analytical technologies in the biomedical and life sciences vol. 1188 (2021): 123061. doi: https://doi.org/10.1016/j.jchromb.2021.123061
Hilaire V, Michel G, Majoor A, Hadji-Minaglou F, Landreau A, Fernandez X. New method for screening anti-Leishmania compounds in plants extracts by HPTLC-bioautography. J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Dec 04;1188:123061. doi: 10.1016/j.jchromb.2021.123061. Epub 2021 Dec 04. PMID: 34894478.
Copy Download .nbib Format: NLM
A cell-based alternative to the mouse potency assay for pharmaceutical type E botulinum antitoxins.

ALTEX

Diamant E, Torgeman A, Epstein E, Mechaly A, David AB, Levin L, Schwartz A, Dor E, Girshengorn M, Barnea A, Mazor O, Zichel R.
PMID: 34798660
ALTEX. 2022;39(1):113-122. doi: 10.14573/altex.2105251. Epub 2021 Nov 19.

The pharmacopeia mouse neutralization assay (PMNA) is the standard method for determining the potency of phar­maceutical botulinum antitoxins. However, a PMNA requires a large number of mice, and, thus, an alternative in vitro method to replace it is needed....

Cite
Diamant E, Torgeman A, Epstein E, et al. A cell-based alternative to the mouse potency assay for pharmaceutical type E botulinum antitoxins. ALTEX. 2021;39(1):113-122doi: 10.14573/altex.2105251.
Diamant, E., Torgeman, A., Epstein, E., Mechaly, A., David, A. B., Levin, L., Schwartz, A., Dor, E., Girshengorn, M., Barnea, A., Mazor, O., & Zichel, R. (2022). A cell-based alternative to the mouse potency assay for pharmaceutical type E botulinum antitoxins. ALTEX, 39(1), 113-122. https://doi.org/10.14573/altex.2105251
Diamant, Eran, et al. "A cell-based alternative to the mouse potency assay for pharmaceutical type E botulinum antitoxins." ALTEX vol. 39,1 (2022): 113-122. doi: https://doi.org/10.14573/altex.2105251
Diamant E, Torgeman A, Epstein E, Mechaly A, David AB, Levin L, Schwartz A, Dor E, Girshengorn M, Barnea A, Mazor O, Zichel R. A cell-based alternative to the mouse potency assay for pharmaceutical type E botulinum antitoxins. ALTEX. 2022;39(1):113-122. doi: 10.14573/altex.2105251. Epub 2021 Nov 19. PMID: 34798660.
Copy Download .nbib Format: NLM
Prestimulus alpha power but not phase influences visual discrimination of long-duration visual stimuli.

The European journal of neuroscience

Michail G, Toran Jenner L, Keil J.
PMID: 33666291
Eur J Neurosci. 2021 Mar 05; doi: 10.1111/ejn.15169. Epub 2021 Mar 05.

Occipital oscillations in the alpha band are closely related to visual perception and attention. In multiple studies, increased alpha power has been shown to reduce detection rates of hard-to-detect visual stimuli. Recent studies explain this finding by a shift...

Cite
Michail G, Toran Jenner L, Keil J. Prestimulus alpha power but not phase influences visual discrimination of long-duration visual stimuli. Eur J Neurosci. 2021;doi: 10.1111/ejn.15169.
Michail, G., Toran Jenner, L., & Keil, J. (2021). Prestimulus alpha power but not phase influences visual discrimination of long-duration visual stimuli. The European journal of neuroscience, . https://doi.org/10.1111/ejn.15169
Michail, Georgios, et al. "Prestimulus alpha power but not phase influences visual discrimination of long-duration visual stimuli." The European journal of neuroscience vol. (2021). doi: https://doi.org/10.1111/ejn.15169
Michail G, Toran Jenner L, Keil J. Prestimulus alpha power but not phase influences visual discrimination of long-duration visual stimuli. Eur J Neurosci. 2021 Mar 05; doi: 10.1111/ejn.15169. Epub 2021 Mar 05. PMID: 33666291.
Copy Download .nbib Format: NLM
Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer.

International journal of particle therapy

Thaker NG, Boyce-Fappiano D, Ning MS, Pasalic D, Guzman A, Smith G, Holliday EB, Incalcaterra J, Garden AS, Shaitelman SF, Gunn GB, Fuller CD, Blanchard P, Feeley TW, Kaplan RS, Frank SJ.
PMID: 34285963
Int J Part Ther. 2021 Jun 25;8(1):374-382. doi: 10.14338/IJPT-20-00042.1. eCollection 2021.

PURPOSE: In value-based health care delivery, radiation oncologists need to compare empiric costs of care delivery with advanced technologies, such as intensity-modulated proton therapy (IMPT) and intensity-modulated radiation therapy (IMRT). We used time-driven activity-based costing (TDABC) to compare the...

Cite
Thaker NG, Boyce-Fappiano D, Ning MS, et al. Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer. Int J Part Ther. 2021;8(1):374-382doi: 10.14338/IJPT-20-00042.1.
Thaker, N. G., Boyce-Fappiano, D., Ning, M. S., Pasalic, D., Guzman, A., Smith, G., Holliday, E. B., Incalcaterra, J., Garden, A. S., Shaitelman, S. F., Gunn, G. B., Fuller, C. D., Blanchard, P., Feeley, T. W., Kaplan, R. S., & Frank, S. J. (2021). Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer. International journal of particle therapy, 8(1), 374-382. https://doi.org/10.14338/IJPT-20-00042.1
Thaker, Nikhil G, et al. "Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer." International journal of particle therapy vol. 8,1 (2021): 374-382. doi: https://doi.org/10.14338/IJPT-20-00042.1
Thaker NG, Boyce-Fappiano D, Ning MS, Pasalic D, Guzman A, Smith G, Holliday EB, Incalcaterra J, Garden AS, Shaitelman SF, Gunn GB, Fuller CD, Blanchard P, Feeley TW, Kaplan RS, Frank SJ. Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer. Int J Part Ther. 2021 Jun 25;8(1):374-382. doi: 10.14338/IJPT-20-00042.1. eCollection 2021. PMID: 34285963; PMCID: PMC8270081.
Copy Download .nbib Format: NLM
An Overview of the Radiation Oncology Alternative Payment Model and Impact on Practices Serving Vulnerable Populations.

Journal of the American College of Radiology : JACR

Luh JY, Jones RT, Thaker NG, Hubbard A, Mohideen N, Golding LP, Rosenthal SA.
PMID: 34762833
J Am Coll Radiol. 2022 Jan;19(1):53-60. doi: 10.1016/j.jacr.2021.09.030. Epub 2021 Nov 08.

Radiation oncology reimbursement methodology has been largely unchanged over the past 30 years, and new approaches are of great interest to practicing radiation oncologists and other health care stakeholders. Traditional radiation oncology reimbursement is based on a series of...

Cite
Luh JY, Jones RT, Thaker NG, et al. An Overview of the Radiation Oncology Alternative Payment Model and Impact on Practices Serving Vulnerable Populations. J Am Coll Radiol. 2021;19(1):53-60doi: 10.1016/j.jacr.2021.09.030.
Luh, J. Y., Jones, R. T., Thaker, N. G., Hubbard, A., Mohideen, N., Golding, L. P., & Rosenthal, S. A. (2022). An Overview of the Radiation Oncology Alternative Payment Model and Impact on Practices Serving Vulnerable Populations. Journal of the American College of Radiology : JACR, 19(1), 53-60. https://doi.org/10.1016/j.jacr.2021.09.030
Luh, Join Y, et al. "An Overview of the Radiation Oncology Alternative Payment Model and Impact on Practices Serving Vulnerable Populations." Journal of the American College of Radiology : JACR vol. 19,1 (2022): 53-60. doi: https://doi.org/10.1016/j.jacr.2021.09.030
Luh JY, Jones RT, Thaker NG, Hubbard A, Mohideen N, Golding LP, Rosenthal SA. An Overview of the Radiation Oncology Alternative Payment Model and Impact on Practices Serving Vulnerable Populations. J Am Coll Radiol. 2022 Jan;19(1):53-60. doi: 10.1016/j.jacr.2021.09.030. Epub 2021 Nov 08. PMID: 34762833.
Copy Download .nbib Format: NLM
Role and Evolution of the Extracellular Matrix in the Acquisition of Complex Multicellularity in Eukaryotes: A Macroalgal Perspective.

Genes

Kloareg B, Badis Y, Cock JM, Michel G.
PMID: 34356075
Genes (Basel). 2021 Jul 10;12(7). doi: 10.3390/genes12071059.

Multicellular eukaryotes are characterized by an expanded extracellular matrix (ECM) with a diversified composition. The ECM is involved in determining tissue texture, screening cells from the outside medium, development, and innate immunity, all of which are essential features in...

Cite
Kloareg B, Badis Y, Cock JM, et al. Role and Evolution of the Extracellular Matrix in the Acquisition of Complex Multicellularity in Eukaryotes: A Macroalgal Perspective. Genes (Basel). 2021;12(7)doi: 10.3390/genes12071059.
Kloareg, B., Badis, Y., Cock, J. M., & Michel, G. (2021). Role and Evolution of the Extracellular Matrix in the Acquisition of Complex Multicellularity in Eukaryotes: A Macroalgal Perspective. Genes, 12(7), . https://doi.org/10.3390/genes12071059
Kloareg, Bernard, et al. "Role and Evolution of the Extracellular Matrix in the Acquisition of Complex Multicellularity in Eukaryotes: A Macroalgal Perspective." Genes vol. 12,7 (2021). doi: https://doi.org/10.3390/genes12071059
Kloareg B, Badis Y, Cock JM, Michel G. Role and Evolution of the Extracellular Matrix in the Acquisition of Complex Multicellularity in Eukaryotes: A Macroalgal Perspective. Genes (Basel). 2021 Jul 10;12(7). doi: 10.3390/genes12071059. PMID: 34356075; PMCID: PMC8307928.
Copy Download .nbib Format: NLM
Payment Methodology for the Radiation Oncology Alternative Payment Model: Implications for Practices and Suggestions for Improvement.

JCO oncology practice

Boyce-Fappiano D, Ning MS, Gjyshi O, Mesko S, Pasalic D, Chang AJ, Orio PF, Thaker NG.
PMID: 34097458
JCO Oncol Pract. 2021 Dec;17(12):761-764. doi: 10.1200/OP.21.00200. Epub 2021 Jun 07.

No abstract available.

Cite
Boyce-Fappiano D, Ning MS, Gjyshi O, et al. Payment Methodology for the Radiation Oncology Alternative Payment Model: Implications for Practices and Suggestions for Improvement. JCO Oncol Pract. 2021;17(12):761-764doi: 10.1200/OP.21.00200.
Boyce-Fappiano, D., Ning, M. S., Gjyshi, O., Mesko, S., Pasalic, D., Chang, A. J., Orio, P. F., & Thaker, N. G. (2021). Payment Methodology for the Radiation Oncology Alternative Payment Model: Implications for Practices and Suggestions for Improvement. JCO oncology practice, 17(12), 761-764. https://doi.org/10.1200/OP.21.00200
Boyce-Fappiano, David, et al. "Payment Methodology for the Radiation Oncology Alternative Payment Model: Implications for Practices and Suggestions for Improvement." JCO oncology practice vol. 17,12 (2021): 761-764. doi: https://doi.org/10.1200/OP.21.00200
Boyce-Fappiano D, Ning MS, Gjyshi O, Mesko S, Pasalic D, Chang AJ, Orio PF, Thaker NG. Payment Methodology for the Radiation Oncology Alternative Payment Model: Implications for Practices and Suggestions for Improvement. JCO Oncol Pract. 2021 Dec;17(12):761-764. doi: 10.1200/OP.21.00200. Epub 2021 Jun 07. PMID: 34097458.
Copy Download .nbib Format: NLM
Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents Study.

HemaSphere

Tabone MD, Kolta S, Auquier P, Vercasson C, Chastagner P, Kanold J, Rohrlich PS, Bertrand Y, Baruchel A, Plantaz D, Gandemer V, Ducassou S, Petit A, Paillard C, Leverger G, Dalle JH, Berbis J, Roux C, Michel G.
PMID: 33458594
Hemasphere. 2021 Jan 12;5(2):e518. doi: 10.1097/HS9.0000000000000518. eCollection 2021 Feb.

This prospective study aimed to analyze determinants that can influence bone mineral density evolution in childhood acute leukemia survivors. Patients included were selected from the long-term follow-up LEA cohort and had dual energy radiograph absorptiometry scan between 10 and...

Cite
Tabone MD, Kolta S, Auquier P, et al. Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents Study. Hemasphere. 2021;5(2):e518doi: 10.1097/HS9.0000000000000518.
Tabone, M. D., Kolta, S., Auquier, P., Vercasson, C., Chastagner, P., Kanold, J., Rohrlich, P. S., Bertrand, Y., Baruchel, A., Plantaz, D., Gandemer, V., Ducassou, S., Petit, A., Paillard, C., Leverger, G., Dalle, J. H., Berbis, J., Roux, C., & Michel, G. (2021). Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents Study. HemaSphere, 5(2), e518. https://doi.org/10.1097/HS9.0000000000000518
Tabone, Marie-Dominique, et al. "Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents Study." HemaSphere vol. 5,2 (2021): e518. doi: https://doi.org/10.1097/HS9.0000000000000518
Tabone MD, Kolta S, Auquier P, Vercasson C, Chastagner P, Kanold J, Rohrlich PS, Bertrand Y, Baruchel A, Plantaz D, Gandemer V, Ducassou S, Petit A, Paillard C, Leverger G, Dalle JH, Berbis J, Roux C, Michel G. Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents Study. Hemasphere. 2021 Jan 12;5(2):e518. doi: 10.1097/HS9.0000000000000518. eCollection 2021 Feb. PMID: 33458594; PMCID: PMC7806242.
Copy Download .nbib Format: NLM
Disproportionate Negative Impact of the Radiation Oncology Alternative Payment Model on Rural Providers: A Cost Identification Analysis of Medicare Claims.

JCO oncology practice

Mantz CA, Thaker NG, Pendyala P, Hubbard A, Eichler TJ, Shah C, Orio PF, Petereit DG.
PMID: 34529516
JCO Oncol Pract. 2021 Dec;17(12):e1977-e1983. doi: 10.1200/OP.21.00330. Epub 2021 Sep 16.

PURPOSE: The Radiation Oncology Alternative Payment Model (APM) is a Medicare demonstration project that will test whether prospective bundled payments to a randomly selected group of physician practices, hospital outpatient departments, and freestanding radiation therapy centers reduce overall expenditures...

Cite
Mantz CA, Thaker NG, Pendyala P, et al. Disproportionate Negative Impact of the Radiation Oncology Alternative Payment Model on Rural Providers: A Cost Identification Analysis of Medicare Claims. JCO Oncol Pract. 2021;17(12):e1977-e1983doi: 10.1200/OP.21.00330.
Mantz, C. A., Thaker, N. G., Pendyala, P., Hubbard, A., Eichler, T. J., Shah, C., Orio, P. F., & Petereit, D. G. (2021). Disproportionate Negative Impact of the Radiation Oncology Alternative Payment Model on Rural Providers: A Cost Identification Analysis of Medicare Claims. JCO oncology practice, 17(12), e1977-e1983. https://doi.org/10.1200/OP.21.00330
Mantz, Constantine A, et al. "Disproportionate Negative Impact of the Radiation Oncology Alternative Payment Model on Rural Providers: A Cost Identification Analysis of Medicare Claims." JCO oncology practice vol. 17,12 (2021): e1977-e1983. doi: https://doi.org/10.1200/OP.21.00330
Mantz CA, Thaker NG, Pendyala P, Hubbard A, Eichler TJ, Shah C, Orio PF, Petereit DG. Disproportionate Negative Impact of the Radiation Oncology Alternative Payment Model on Rural Providers: A Cost Identification Analysis of Medicare Claims. JCO Oncol Pract. 2021 Dec;17(12):e1977-e1983. doi: 10.1200/OP.21.00330. Epub 2021 Sep 16. PMID: 34529516.
Copy Download .nbib Format: NLM
New method for screening anti-Leishmania compounds in plants extracts by HPTLC-bioautography.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Hilaire V, Michel G, Majoor A, Hadji-Minaglou F, Landreau A, Fernandez X.
PMID: 34894478
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Dec 04;1188:123061. doi: 10.1016/j.jchromb.2021.123061. Epub 2021 Dec 04.

Leishmania genus is responsible for leishmaniasis, a group of diseases affecting 12 million people in the tropical and subtropical zone. Currently, the few drugs that are available to treat this disease are expensive and cause many side effects. Searching...

Cite
Hilaire V, Michel G, Majoor A, et al. New method for screening anti-Leishmania compounds in plants extracts by HPTLC-bioautography. J Chromatogr B Analyt Technol Biomed Life Sci. 2021;1188:123061doi: 10.1016/j.jchromb.2021.123061.
Hilaire, V., Michel, G., Majoor, A., Hadji-Minaglou, F., Landreau, A., & Fernandez, X. (2021). New method for screening anti-Leishmania compounds in plants extracts by HPTLC-bioautography. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1188123061. https://doi.org/10.1016/j.jchromb.2021.123061
Hilaire, Valentin, et al. "New method for screening anti-Leishmania compounds in plants extracts by HPTLC-bioautography." Journal of chromatography. B, Analytical technologies in the biomedical and life sciences vol. 1188 (2021): 123061. doi: https://doi.org/10.1016/j.jchromb.2021.123061
Hilaire V, Michel G, Majoor A, Hadji-Minaglou F, Landreau A, Fernandez X. New method for screening anti-Leishmania compounds in plants extracts by HPTLC-bioautography. J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Dec 04;1188:123061. doi: 10.1016/j.jchromb.2021.123061. Epub 2021 Dec 04. PMID: 34894478.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 378 entries